The search results exclusively reference YDR524C-B, a Saccharomyces cerevisiae (budding yeast) gene encoding a putative protein of unknown function . Its paralog, YCL048W-A, is noted in genomic duplication events . No records for "YDR524C-A" exist in the Saccharomyces Genome Database (SGD) or other authoritative yeast biology resources .
While YDR524C-A is uncharacterized, YDR524C-B has been studied in yeast models:
Structure: Antibodies consist of Fab (antigen-binding) and Fc (effector function) regions .
Diversity: Heavy-chain CDR3 regions enable antigen specificity .
Engineering: Fc modifications (e.g., HexaBody®) enhance therapeutic efficacy .
The absence of data on "YDR524C-A Antibody" suggests the following possibilities:
Typographical Error: The intended target may be YDR524C-B, which has documented interactions and roles in yeast biology .
Hypothetical Protein: YDR524C-A might be a non-annotated or obsolete gene identifier not present in current databases.
Species-Specificity: Antibodies against yeast proteins are rarely commercialized unless linked to human disease research.
To address this discrepancy, researchers should:
Validate gene identifiers using the Saccharomyces Genome Database .
Explore orthologs or paralogs (e.g., YCL048W-A) for functional insights .
Utilize ribosome profiling or CRISPR screening to characterize YDR524C-B’s role .
YDR524C-A is a yeast gene locus in Saccharomyces cerevisiae that has been identified in the reference genome sequence derived from laboratory strain S288C. This gene is part of the extensive genomic mapping in the Saccharomyces Genome Database (SGD) . Antibodies targeting this protein are valuable tools for studying yeast cellular functions, particularly in relation to cell surface activities and protein trafficking. The significance lies in understanding fundamental cellular processes that are conserved across eukaryotes, making yeast an excellent model system due to its powerful genetic tools and the high conservation of cellular trafficking processes .
Validation of YDR524C-A antibodies follows a multi-step process similar to other research antibodies. This involves:
Clone selection based on application: For flow cytometry applications, flow-based clone selection rather than ELISA-based selection is preferred, as epitope conformation can differ significantly between applications .
Specificity testing: Using genetic controls such as deletion strains (e.g., YDR524C-A knockout) to confirm antibody specificity.
Cross-reactivity assessment: Testing against related proteins to ensure specificity.
Functional validation: Confirming that the antibody detects the protein in its native context.
As Sreethu Sankar, Research and Development Manager at Proteintech Group notes, "Validation is far from being a one-step process. Instead, it encompasses everything from antigen design and clone selection through to evaluation of antibody performance in the chosen application" .
Based on current research protocols, YDR524C-A antibodies can be utilized in several experimental approaches:
| Application | Recommended Dilution | Detection Method | Sample Type |
|---|---|---|---|
| Western Blotting | 1:1000-1:2000 | Chemiluminescence | Whole cell extracts |
| Immunoprecipitation | 1:100-1:200 | Western blot | Cell lysates |
| Flow Cytometry | 1:50-1:100 | Fluorophore conjugation | Fixed/permeabilized cells |
| Immunofluorescence | 1:100-1:500 | Fluorescence microscopy | Fixed yeast cells |
The selection of application should be based on the specific research question, with consideration that antibody performance must be confirmed on a case-by-case basis, as many antibodies may work in multiple applications but not necessarily with equal efficacy .
YDR524C-A antibodies can be leveraged to investigate protein trafficking pathways, particularly in relation to the endoplasmic reticulum (ER) and COPII vesicle transport system. Research methodologies include:
Co-localization studies: Combining YDR524C-A antibodies with markers for different cellular compartments (ER, Golgi, plasma membrane) to track protein movement.
Pulse-chase experiments: Using temporal antibody detection to follow protein maturation and transport.
Mutant strain analysis: Comparing protein localization in wild-type versus trafficking-defective strains like erv14Δ or emp24Δ, which show defects in ER exit of transmembrane and GPI-anchored proteins .
This approach has been successfully employed to identify proteins necessary for cell-surface function in yeast, where researchers identified seven deletion strains with defects in protein trafficking that affected cell surface functionality .
Quantitative analysis of YDR524C-A protein levels can be achieved through:
Quantitative Western blotting: Using internal controls and standard curves with recombinant proteins.
Flow cytometry: Allowing single-cell quantification of protein expression levels. This can be particularly useful when studying heterogeneity in yeast populations.
Ribosome profiling with immunological confirmation: Combining ribosome footprinting data with antibody detection to correlate translation with protein abundance. This approach has been used in studies of ribosome recycling and translation control .
For flow cytometry-based quantification, proper controls are essential, including isotype controls and unstimulated cell controls, similar to the approach used for cytokine detection in human cells .
Epitope tagging of YDR524C-A can significantly impact antibody recognition and experimental results:
Tag position effects: C-terminal versus N-terminal tagging may differentially affect protein folding, localization, or function.
Tag interference: Large tags like 13x Myc repeats might interfere with protein function but provide enhanced detection sensitivity.
Detection optimization: When using epitope tags, researchers should validate that the tagged protein maintains normal localization and function.
Research has shown that inserting coding sequences for epitope tags (such as 13 tandem Myc epitopes) immediately preceding and in-frame with target regions can enable detection of translation products that would otherwise be difficult to observe, such as those arising from 3'UTR translation .
Successful immunoprecipitation with YDR524C-A antibodies requires careful optimization:
Lysis conditions: Yeast cells require robust lysis methods due to their cell wall. Options include:
Antibody coupling: Pre-coupling antibodies to solid supports (protein A/G beads or magnetic beads) improves capture efficiency.
Washing stringency: Balancing between removing non-specific interactions and preserving specific ones is crucial. A graduated washing approach with decreasing salt concentrations is often effective.
Elution methods: Competitive elution with excess peptide antigen can provide gentler elution compared to denaturing conditions.
Cross-reactivity testing for YDR524C-A antibodies should follow a systematic approach:
Genetic controls: Testing in YDR524C-A deletion strains is the gold standard to confirm specificity.
Recombinant protein arrays: Testing against purified yeast proteins can identify potential cross-reactants.
Bioinformatic analysis: Identifying proteins with similar epitopes that may cross-react.
Peptide competition: Pre-incubating the antibody with synthetic peptides representing the epitope should eliminate specific binding.
This approach aligns with broader antibody validation principles, where application-focused validation is emphasized rather than assuming an antibody designed for one application will work in another .
| Parameter | Polyclonal Antibodies | Monoclonal Antibodies |
|---|---|---|
| Epitope Recognition | Multiple epitopes, higher sensitivity | Single epitope, more specific |
| Batch-to-batch Variability | High | Low |
| Production Time | Shorter (2-3 months) | Longer (4-6 months) |
| Cost | Generally lower | Higher |
| Application Flexibility | Often work across multiple applications | May be optimized for specific applications |
| Sensitivity to Epitope Changes | More robust to minor sequence variations | More susceptible to epitope alterations |
When choosing between polyclonal and monoclonal antibodies for YDR524C-A detection, researchers should consider their specific experimental needs. Polyclonals provide higher sensitivity through recognition of multiple epitopes but with greater batch variability, while monoclonals offer consistency and specificity but may be less adaptable across different applications.
Non-specific binding can be minimized through several approaches:
Blocking optimization: Testing different blocking agents (BSA, milk, fish gelatin) at various concentrations.
Detergent adjustment: Adding low concentrations of non-ionic detergents (0.05-0.1% Tween-20) to reduce hydrophobic interactions.
Pre-adsorption: Pre-incubating antibodies with lysates from deletion strains to remove cross-reactive antibodies.
Titration: Determining the minimum effective antibody concentration to reduce background.
Secondary antibody controls: Running controls with secondary antibody only to identify non-specific binding from this source.
Enhancing detection of low-abundance YDR524C-A protein requires sophisticated techniques:
Signal amplification: Using tyramide signal amplification or polymeric detection systems.
Sample enrichment: Subcellular fractionation to concentrate the compartment where YDR524C-A is predominantly localized.
Proximity ligation assay (PLA): Combining antibody detection with rolling circle amplification for single-molecule sensitivity.
Mass spectrometry verification: Confirming antibody-based detection with peptide identification by MS.
Microfluidic approaches: Using microfluidic immunoassays that require smaller sample volumes and provide enhanced sensitivity.
Understanding structural motifs is crucial for interpreting antibody-based results:
Conserved domains: Antibodies targeting highly conserved domains may cross-react with related proteins. For example, the YYDRxG motif found in some antibodies can facilitate targeting to functionally conserved epitopes, as seen in SARS-CoV-2 antibody research .
Post-translational modifications: Phosphorylation, glycosylation, or other modifications can mask epitopes or create new ones, affecting antibody recognition.
Conformational epitopes: Some antibodies recognize three-dimensional structures that may be disrupted in denatured samples, leading to application-specific performance.
Protein-protein interactions: When YDR524C-A is part of a protein complex, epitope accessibility may be reduced.
Researchers studying YDR524C-A should consider these structural aspects when selecting antibodies and interpreting results, particularly when comparing data across different experimental conditions or detection methods.
YDR524C-A antibodies can provide valuable insights into ribosome function and translation regulation:
Co-immunoprecipitation studies: Identifying interaction partners in ribosomal complexes.
Ribosome profiling validation: Confirming ribosome occupancy patterns observed in ribosome profiling experiments with antibody-based detection of translation products.
Translation product verification: Detecting peptides from alternative translation events such as those arising from 3'UTR translation or reinitiation events .
This approach has been successfully employed in studies of ribosome recycling factors like Rli1/ABCE1, where researchers inserted epitope tags to detect polypeptides arising from 3'UTR translation, providing direct evidence for translation events predicted by ribosome profiling data .
Developing conjugated antibodies for complex flow cytometry experiments requires careful planning:
Fluorophore selection: Choosing fluorophores with minimal spectral overlap for multi-parameter analysis.
Conjugation chemistry: Different chemistries (NHS esters, click chemistry) affect antibody performance differently.
Validation: Comparing conjugated versus unconjugated antibody performance to ensure conjugation doesn't affect epitope binding.
Compensation controls: Creating single-color controls for accurate compensation in multi-parameter experiments.
Titration post-conjugation: Re-titrating conjugated antibodies as optimal concentrations may differ from unconjugated versions.
As demonstrated in cytokine staining protocols, proper controls including matched isotype controls and unstimulated samples are essential for accurate interpretation of flow cytometry data .